PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Nov-2023 Ribometrix Announces Lead Program Target and Presentation of Preclinical Data at the International Congress of the Society for Melanoma Research Businesswire
06-Nov-2023 Verastem Oncology Announces Efficacy and Safety Data of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) in Heavily Pretreated Patient Population Businesswire
06-Nov-2023 Volastra Therapeutics Appoints David Nicholson, Ph.D., to Board of Directors Businesswire
06-Nov-2023 Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023 Businesswire
06-Nov-2023 US Anesthesia Drugs and Devices Market Set to Reach $6.83 Billion in 2023, Driven by Growing Healthcare Expenditure - ResearchAndMarkets.com Businesswire
06-Nov-2023 Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum Newswire
06-Nov-2023 Enhanc3D Genomics Expands Leadership Team With the Appointment of Hazel Jones as Chief Operating Officer Businesswire
06-Nov-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Nov-2023 Change in Leadership at Daiichi Sankyo Europe Businesswire
06-Nov-2023 MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT Businesswire
06-Nov-2023 Nexa3D Announces Intent to Acquire Essentium; Adds High Speed Extrusion to its Product Portfolio Businesswire
06-Nov-2023 Inotrem Receives Milestone Funding From the Crohn’s & Colitis Foundation IBD Ventures Program to Advance Its Inflammatory Bowel Disease Pipeline Businesswire
05-Nov-2023 Beaconcure Announces Launch of Automated Validation of Statistical Analysis Outputs Against ADaM Datasets Businesswire
04-Nov-2023 Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications Businesswire
04-Nov-2023 Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study Businesswire
04-Nov-2023 Maze Therapeutics Highlights New Preclinical Data Supporting Advancement of APOL1 Inhibitor Candidate Toward Clinical Evaluation for APOL1 Kidney Disease Businesswire
04-Nov-2023 CORRECTING and REPLACING PHOTO Boveda® Inc. Acquires FreshStor Elevating Cannabis Storage Businesswire
04-Nov-2023 Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I Businesswire
03-Nov-2023 Hudson Therapeutics, Inc. Appoints Janice Marie McCourt as co-Chief Executive Officer and Board Member Businesswire
03-Nov-2023 Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Businesswire